Inhibition of mTOR Signalling: A Potential Anti-aging Drug Strategy

  • Komal Saraswat
  • Raushan Kumar
  • Syed Ibrahim Rizvi


Maintenance of cellular energy homeostasis, counterbalanced by cellular stress response and an adequate cellular housekeeping are the hallmarks of improved healthspan and lifespan. Mammalian target of rapamycin (mTOR) is a central cell growth regulator that integrates cellular growth and proliferation with nutrient status of the cell. It is an intracellular nutrient sensor that controls protein synthesis, cell growth and metabolism. mTOR turns off stress resistance and autophagy and activates translation. Available scientific evidence endorses that molecular inhibition of this pathway slows aging, extends lifespan and improves symptoms of diverse array of age-related diseases in wide range of species. Rapamycin, a small molecule inhibitor of the protein kinase mTOR, has been found to extend the lifespan of model organisms including mice. Many of such inhibitors of this pathway are already characterized and clinically approved. In the present chapter, we summarize current understanding of mTOR and its role in aging and age-related disease progression.


Aging Autophagy Mammalian target of rapamycin Protein synthesis Rapamycin 


  1. Alvers AL, Wood MS, Hu D et al (2009) Autophagy is required for extension of yeast chronological life span by rapamycin. Autophagy 5:847–849. CrossRefPubMedPubMedCentralGoogle Scholar
  2. Anisimov VN, Zabezhinski MA, Popovich IG et al (2011) Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice. Cell Cycle 10:4230–4236. CrossRefPubMedGoogle Scholar
  3. Blagosklonny MV (2010) Calorie restriction: decelerating mTOR-driven aging from cells to organisms (including humans). Cell Cycle 9:683–688. CrossRefPubMedGoogle Scholar
  4. Blagosklonny MV (2012) Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging. Aging 4:159–165. CrossRefPubMedPubMedCentralGoogle Scholar
  5. Chen C, Liu Y, Liu Y, Zheng P (2009) mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Sci Signal 2:ra75–ra75. CrossRefPubMedPubMedCentralGoogle Scholar
  6. Demidenko ZN, Blagosklonny MV (2008) Growth stimulation leads to cellular senescence when the cell cycle is blocked. Cell Cycle 7:3355–3361. CrossRefPubMedGoogle Scholar
  7. DeYoung MP, Horak P, Sofer A et al (2008) Hypoxia regulates TSC1/2 mTOR signaling and tumor suppression through REDD1-mediated 14 3 3 shuttling. Genes Dev 22:239–251. CrossRefPubMedPubMedCentralGoogle Scholar
  8. Ehninger D, Neff F, Xie K (2014) Longevity, aging and rapamycin. Cell Mol Life Sci 71:4325–4346. CrossRefPubMedPubMedCentralGoogle Scholar
  9. Fischer KE, Gelfond JAL, Soto VY et al (2015) Health effects of long-term rapamycin treatment: the impact on mouse health of enteric rapamycin treatment from four months of age throughout life. PLoS One 10:e0126644. CrossRefPubMedPubMedCentralGoogle Scholar
  10. Glick D, Barth S, Macleod KF (2010) Autophagy: cellular and molecular mechanisms. J Pathol 221:3–12. CrossRefPubMedPubMedCentralGoogle Scholar
  11. Goberdhan DCI, Wilson C, Harris AL (2016) Amino acid sensing by mTORC1: intracellular transporters mark the spot. Cell Metab 23:580–589. CrossRefPubMedPubMedCentralGoogle Scholar
  12. Gwinn DM, Shackelford DB, Egan DF et al (2008) AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 30:214–226. CrossRefPubMedPubMedCentralGoogle Scholar
  13. Hansen M, Chandra A, Mitic LL et al (2008) A role for autophagy in the extension of lifespan by dietary restriction in C. elegans. PLoS Genet 4:e24. CrossRefPubMedPubMedCentralGoogle Scholar
  14. Harrison DE, Strong R, Sharp ZD et al (2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. CrossRefGoogle Scholar
  15. He L, Lu J, Yue Z (2013) Autophagy in ageing and ageing-associated diseases. Acta Pharmacol Sin 34:605–611. CrossRefPubMedPubMedCentralGoogle Scholar
  16. Inoki K, Ouyang H, Li Y, Guan K-L (2005) Signaling by target of rapamycin proteins in cell growth control. Microbiol Mol Biol Rev 69:79–100. CrossRefPubMedPubMedCentralGoogle Scholar
  17. Inoki K, Ouyang H, Zhu T et al (2006) TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 126:955–968. CrossRefPubMedGoogle Scholar
  18. Johnson SC, Rabinovitch PS, Kaeberlein M (2013) mTOR is a key modulator of ageing and age-related disease. Nature 493:338–345. CrossRefPubMedPubMedCentralGoogle Scholar
  19. Kaplan B, Qazi Y, Wellen JR (2014) Strategies for the management of adverse events associated with mTOR inhibitors. Transplant Rev 28:126–133. CrossRefGoogle Scholar
  20. Kunz J, Henriquez R, Schneider U et al (1993) Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression. Cell 73:585–596CrossRefGoogle Scholar
  21. Lamming DW, Ye L, Sabatini DM, Baur JA (2013) Rapalogs and mTOR inhibitors as anti-aging therapeutics. J Clin Investig 123:980–989. CrossRefPubMedGoogle Scholar
  22. Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149:274–293. CrossRefPubMedPubMedCentralGoogle Scholar
  23. Lee S-G, Kaya A, Avanesov AS et al (2017) Age-associated molecular changes are deleterious and may modulate life span through diet. Sci Adv 3:e1601833. CrossRefPubMedPubMedCentralGoogle Scholar
  24. Mendoza MC, Er EE, Blenis J (2011) The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. Trends Biochem Sci 36:320–328. CrossRefPubMedPubMedCentralGoogle Scholar
  25. Mihaylova MM, Shaw RJ (2011) The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 13:1016–1023. CrossRefPubMedPubMedCentralGoogle Scholar
  26. Miller RA, Harrison DE, Astle CM et al (2014) Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction. Aging Cell 13:468–477. CrossRefPubMedPubMedCentralGoogle Scholar
  27. Morris RE (1992) Rapamycins: antifungal, antitumor, antiproliferative, and immunosuppressive macrolides. Transplant Rev 6:39–87. CrossRefGoogle Scholar
  28. Oh WJ, Jacinto E (2011) mTOR complex 2 signaling and functions. Cell Cycle 10:2305–2316. CrossRefPubMedPubMedCentralGoogle Scholar
  29. Pan Y, Schroeder EA, Ocampo A et al (2011) Regulation of yeast chronological life span by TORC1 via adaptive mitochondrial ROS signaling. Cell Metab 13:668–678. CrossRefPubMedPubMedCentralGoogle Scholar
  30. Periyasamy-Thandavan S, Jiang M, Schoenlein P, Dong Z (2009) Autophagy: molecular machinery, regulation, and implications for renal pathophysiology. Am J Physiol Renal Physiol 297:F244–F256. CrossRefPubMedPubMedCentralGoogle Scholar
  31. Peterson TR, Laplante M, Thoreen CC et al (2009) DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell 137:873–886. CrossRefPubMedPubMedCentralGoogle Scholar
  32. Ruetenik A, Barrientos A (2015) Dietary restriction, mitochondrial function and aging: from yeast to humans. Biochim Biophys Acta (BBA) – Bioenerg 1847:1434–1447. CrossRefGoogle Scholar
  33. Sabatini DM, Erdjument-Bromage H, Lui M et al (1994) RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78:35–43CrossRefGoogle Scholar
  34. Sabers CJ, Martin MM, Brunn GJ et al (1995) Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. J Biol Chem 270:815–822CrossRefGoogle Scholar
  35. Sancak Y, Thoreen CC, Peterson TR et al (2007) PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell 25:903–915. CrossRefPubMedGoogle Scholar
  36. Sancak Y, Bar-Peled L, Zoncu R et al (2010) Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 141:290–303. CrossRefPubMedPubMedCentralGoogle Scholar
  37. Saraswat K, Rizvi SI (2017) Novel strategies for anti-aging drug discovery. Expert Opin Drug Discov 12:955–966. CrossRefPubMedGoogle Scholar
  38. Schneider A, Younis RH, Gutkind JS (2008) Hypoxia-induced energy stress inhibits the mTOR pathway by activating an AMPK/REDD1 signaling Axis in head and neck squamous cell carcinoma. Neoplasia 10:1295–1302. CrossRefPubMedPubMedCentralGoogle Scholar
  39. Sengupta S, Peterson TR, Sabatini DM (2010) Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell 40:310–322. CrossRefPubMedPubMedCentralGoogle Scholar
  40. Showkat M, Beigh MA, Andrabi KI (2014) mTOR signaling in protein translation regulation: implications in cancer genesis and therapeutic interventions. Mol Biol Int 2014:1–14. CrossRefGoogle Scholar
  41. Singh AK, Kashyap MP, Tripathi VK et al (2016) Neuroprotection through rapamycin-induced activation of autophagy and PI3K/Akt1/mTOR/CREB signaling against amyloid-β-induced oxidative stress, synaptic/neurotransmission dysfunction, and neurodegeneration in adult rats. Mol Neurobiol. CrossRefGoogle Scholar
  42. Singh AK, Garg G, Singh S, Rizvi SI (2017a) Synergistic effect of rapamycin and metformin against age-dependent oxidative stress in rat erythrocytes. Rejuvenation Res 20:420–429. CrossRefPubMedGoogle Scholar
  43. Singh AK, Singh S, Garg G, Rizvi SI (2017b) Rapamycin mitigates erythrocyte membrane transport functions and oxidative stress during aging in rats. Arch Physiol Biochem 1–9. CrossRefGoogle Scholar
  44. Tee AR, Manning BD, Roux PP et al (2003) Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr Biol 13:1259–1268. CrossRefPubMedGoogle Scholar
  45. Thedieck K, Polak P, Kim ML et al (2007) PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis. PLoS One 2:e1217. CrossRefPubMedPubMedCentralGoogle Scholar
  46. Wang L, Harris TE, Roth RA, Lawrence JC (2007) PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding. J Biol Chem 282:20036–20044. CrossRefPubMedGoogle Scholar
  47. Wullschleger S, Loewith R, Hall MN (2006) TOR signaling in growth and metabolism. Cell 124:471–484. CrossRefPubMedGoogle Scholar
  48. Xu J, Ji J, Yan X-H (2012) Cross-talk between AMPK and mTOR in regulating energy balance. Crit Rev Food Sci Nutr 52:373–381. CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  • Komal Saraswat
    • 1
  • Raushan Kumar
    • 1
  • Syed Ibrahim Rizvi
    • 1
  1. 1.Department of BiochemistryUniversity of AllahabadAllahabadIndia

Personalised recommendations